Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Strategic vaccine production centre
Firm to make major investment in biotechnology

Firm to build one of Europe’s largest biotechnology production sites

Boehringer Ingelheim is developing one of the largest biotechnology production sites for veterinary vaccines in Europe.

The first brick was symbolically laid for the complex on 20 September at the facility’s location in the commune of Jonage, in the eastern part of the Lyon metropolitan area.

The firm predicts that the investment of more than 200 million euros will significantly increase production capacities for antigens and vaccines against highly contagious diseases – such as foot-and-mouth disease and bluetongue disease – providing the means to fight animal epidemics that often have dramatic health and financial consequences.

This high-security, 15,000m2 building will begin operating during the third quarter of 2022. Its five floors will be home to 35 cell and virus culture tanks, a purification area, a decontamination station and a strategic active ingredient reserve.

The antigen bank will enable the company to respond to orders quickly and efficiently in case of an epizootic outbreak of foot-and-mouth disease or bluetongue disease. With this new site, the company is creating more than 100 skilled jobs.

“In the future, we will be able to supply millions of doses in a few days from Lyon for ring vaccination in affected areas to stop the progression of disease. This is a major challenge given the impact of epidemics in the animal population,” explains Erick Lelouche, president of Boehringer Ingelheim Animal Health France.

Boehringer Ingelheim is claimed to be the second largest animal health business in the world, with net sales of almost four billion euros in 2018 and presence in more than 150 markets.

Become a member or log in to add this story to your CPD history

Do you know a practice wellbeing star?

News Story 1
 Has someone in your practice team gone above and beyond to make your workplace a positive one during the coronavirus pandemic? Then why not nominate them for a 2020 Practice Wellbeing Star!

The joint RCVS Mind Matters Initiative/SPVS Practice Wellbeing Star nominations recognise individuals who have held up morale during a time when practices are facing unprecedented staffing and financial issues.

Nominees receive a certificate in recognition of their colleagues' appreciation of their achievements and will be entered into the prize draw for a pair of tickets to attend the joint SPVS and Veterinary Management Group Congress in January 2021.


Click here for more...
News Shorts
WellVet reopens ticket sales to online conference platform

Following the success of its online conference, the organisers behind WellVet Weekend have re-opened ticket sales to allow new delegates to access session recordings and its online networking platform.

The day-long conference saw more than 360 veterinary professionals mix activity sessions with personal development CPD, all hosted within a virtual conference platform. Now, with more than 500 minutes of CPD available, the resource is being re-opened to allow full access to the session recordings until May 2021.

Sessions are aimed at providing delegates with a range of proactive wellbeing tools to explore to find ways of improving their mental and physical health. Tickets are limited in number and on sale at until 30th August 2020.